Form 4 for TECX Tectonic Therapeutic, Inc.
Accepted 2025-01-29 00:00:00 ET · period of report 2025-01-28 · accession 0001415889-25-002262 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-01-29 | 2025-01-28 | TECX | Schwabish Marc | Chief Business Off | M - OptEx | $2.38 | +2,700 | 4,700 | +135% | +$6,426 |
| D | 2025-01-29 | 2025-01-28 | TECX | Schwabish Marc | Chief Business Off | M - OptEx | — | -2,700 | 86.5K | -3% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-28 | M | A | 2,700 | $2.38 | 4,700 | D | — | — | |
| 2 | Derivative | Employee Stock Option (Right to Buy) | 2025-01-28 | M | D | 2,700 | — | 86,514 | D | $2.38 · — to 2031-06-27 | 2,700 Common Stock | (F2) Received in exchange for a stock option to acquire 170,679 shares of common stock pursuant to that certain merger, as more fully described on the Reporting Person's Form 4 filed with the Securities and Exchange Commission on June 24, 2024. https://www.sec.gov/Archives/edgar/data/1681087/000141588924017972/xslF345X05/form4-06242024_080616.xml (F1) The shares subject to the option vest as to 25% of the shares on March 15, 2022 with the remainder vesting in the following 36 equal monthly installments, subject to the Reporting Person's continued service on each such vesting date. |